Add to BibSonomyAbstract
Breast cancer has become the most diagnosed cancer globally, replacing lung cancer in 2020, with 2.3 million new cases and an estimated death of 685000 women. It is predicted that by the year of 2040 there would be an increase to around 3 million new cases and 1 million deaths worldwide. This calls for techniques for better and faster diagnosis, and in understanding the different biomarkers and the resulting metabolic alterations aiding the development and progression of the tumour. Obesity is associated with metabolic alterations that have shown to increase the risk of cancer and worsen its prognosis. It is associated with dysfunction of adipose tissue that alter the lipid metabolism resulting in excessive accumulation of adipose tissue at sites other than where they are classically found.
© 2023 SPIE
PDF ArticleMore Like This
L. Pioppi, R. Parvan, A. Samrend, G. Justo da Silva, M. Paolantoni, A. Cataliotti, and P. Sassi
1262709 European Conference on Biomedical Optics (ECBO) 2023
Amir Y. Sajjadi, Steven J. Isakoff, Christy M. Wanyo, Qianqian Fang, Michelle C. Specht, Lidia Schapira, Beverly Moy, Aditya Bardia, David A. Boas, and Stefan A. Carp
BW4B.5 Biomedical Optics (BIOMED) 2014
M.J. Remmelink, Y. Rip, P.R Bloemen, R.M. van den Elzen, J.R. Oddens, J.A. Nieuwenhuijzen, J.P. van der Voorn, T.G. van Leeuwen, T.M. de Reijke, and D.M. de Bruin
126271Q European Conference on Biomedical Optics (ECBO) 2023